Pacira BioSciences, Inc. (PCRX)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 170,428 | 184,669 | 199,295 | 140,255 | 117,328 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $170,428K ÷ $—K
= —
Based on the provided data, the payables turnover ratio for Pacira BioSciences, Inc. is not available for the years 2020, 2021, 2022, 2023, and 2024. The payables turnover ratio is a financial metric that indicates how quickly a company pays its suppliers. Without the specific values for payables turnover, it is challenging to assess the efficiency of Pacira BioSciences in managing its accounts payable and the frequency at which it settles its liabilities with suppliers. Further insight or additional data would be necessary to evaluate the company's payables turnover performance accurately.
Peer comparison
Dec 31, 2024